• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Mettler-Toledo International Inc. Reports Third Quarter 2024 Results

    11/7/24 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email

    Mettler-Toledo International Inc. (NYSE:MTD) today announced third quarter results for 2024. Provided below are the highlights:

    • Reported and local currency sales increased 1% compared with the prior year.
    • Net earnings per diluted share as reported (EPS) were $9.96, compared with $9.21 in the prior-year period. Adjusted EPS was $10.21, an increase of 4% over the prior-year amount of $9.80. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules.

    Third Quarter Results

    Patrick Kaltenbach, President and Chief Executive Officer, stated, "We experienced good growth during the third quarter in our Laboratory business and had particularly strong growth in Service. While China grew modestly this quarter, market conditions remain challenging, particularly in the Industrial sector. We are very pleased with our team's strong execution of our growth and margin expansion initiatives, which supported good earnings growth."

    GAAP Results

    EPS in the quarter was $9.96, compared with the prior-year amount of $9.21.

    Compared with the prior year, total reported sales rose 1% to $954.5 million. By region, reported sales increased 2% in Europe and 4% in Asia/Rest of World and declined 1% in the Americas. Earnings before taxes amounted to $259.0 million, compared with $251.2 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $10.21, an increase of 4% over the prior-year amount of $9.80.

    Compared with the prior year, total sales in local currency increased 1%. By region, local currency sales increased 1% in Europe and 4% in Asia/Rest of World and declined 1% in the Americas. Adjusted Operating Profit amounted to $296.6 million, compared with the prior-year amount of $296.0 million.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Nine Month Results

    GAAP Results

    EPS was $28.55, compared with the prior-year amount of $27.37, and included a non-cash discrete tax benefit of $1.07 per share.

    Compared with the prior year, total reported sales declined 1% to $2.827 billion. By region, reported sales increased 5% in Europe and 1% in the Americas and declined 8% in Asia/Rest of World. Earnings before taxes amounted to $722.7 million, compared with $741.2 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $28.74, compared with the prior-year amount of $28.63.

    Compared with the prior year, total sales in local currency were flat as currency reduced sales growth by 1%. By region, local currency sales increased 4% in Europe and 1% in the Americas and declined 6% in Asia/Rest of World. Excluding the first quarter benefit from delayed fourth quarter 2023 shipments, year-to-date local currency sales declined 2%, including flat sales in Europe and the Americas and a 7% decline in Asia/Rest of World. Adjusted Operating Profit amounted to $848.0 million, compared with the prior-year amount of $870.1 million.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Outlook

    Management cautions that market conditions are uncertain and could change quickly. Based on today's assessment, management anticipates local currency sales for the fourth quarter of 2024 will increase approximately 8%, which includes a benefit of approximately 6% from the previously disclosed shipping delays in the fourth quarter of 2023. Adjusted EPS is forecast to be $11.63 to $11.78, representing growth of 24% to 25%.

    For the full year, management anticipates local currency sales will increase approximately 2%, which includes a benefit of approximately 3% from the previously disclosed shipping delays in the fourth quarter of 2023 that benefited the first quarter of 2024. Adjusted EPS is forecast to be in the range of $40.35 to $40.50, representing growth of approximately 6%. This compares with previous local currency sales growth guidance of approximately 2% and Adjusted EPS guidance of $40.20 to $40.50. Included in the 2024 guidance is an estimated 2% headwind to Adjusted EPS growth due to adverse currency.

    The Company stated that based on its assessment of market conditions today, management anticipates local currency sales growth of approximately 3% in 2025, including a headwind to growth of approximately 1.5% due to the previously mentioned 2023 shipping delays that benefited 2024. This is expected to result in Adjusted EPS in the range of $41.85 to $42.50, representing growth of approximately 4% to 5%.

    The Company does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort the timing and amount of future restructuring and other non-recurring items.

    Conclusion

    Kaltenbach concluded, "We continue to execute very well and will benefit from the prior-year shipping delays in the fourth quarter; however, global market conditions remain soft. We have introduced many exciting innovations, as well as next generations of our Spinnaker sales and marketing and SternDrive productivity programs, over the past year. We also continue to leverage our business diversity and ability to provide value throughout our customers' value chain to identify and capture growth opportunities and believe we are very well positioned to gain market share and deliver good earnings growth in the future."

    Other Matters

    The Company will host a conference call to discuss its quarterly results tomorrow morning (Friday, November 8) at 8:30 a.m. Eastern Time. To listen to a live webcast or replay of the call, visit the investor relations page on the Company's website at investor.mt.com. The presentation referenced on the conference call will be located on the website prior to the call.

    METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

    Forward-Looking Statements Disclaimer

    You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth, inflation, ongoing developments related to Ukraine, and the Israel-Hamas war. You can identify forward-looking statements by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential," or "continue."

    We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, and the impact of inflation, ongoing developments related to Ukraine, and the Israel-Hamas war on our business.

    Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including inflation, ongoing developments related to Ukraine, and the Israel-Hamas war. See in particular "Factors Affecting Our Future Operating Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations."

     

    METTLER-TOLEDO INTERNATIONAL INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (amounts in thousands except share data)

    (unaudited)

     

     

    Three months ended

     

     

     

     

    Three months ended

     

     

     

    September 30, 2024

     

     

    % of sales

     

    September 30, 2023

     

    % of sales

     
    Net sales

    $

    954,535

     

    (a)

    100.0

     

    $

    942,462

     

    100.0

     

    Cost of sales

     

    382,068

     

    40.0

     

     

    382,923

     

    40.6

     

    Gross profit

     

    572,467

     

    60.0

     

     

    559,539

     

    59.4

     

     
    Research and development

     

    47,117

     

    4.9

     

     

    46,127

     

    4.9

     

    Selling, general and administrative

     

    228,777

     

    24.0

     

     

    217,447

     

    23.1

     

    Amortization

     

    18,243

     

    1.9

     

     

    18,314

     

    1.9

     

    Interest expense

     

    18,599

     

    1.9

     

     

    20,278

     

    2.2

     

    Restructuring charges

     

    2,631

     

    0.3

     

     

    7,385

     

    0.8

     

    Other charges (income), net

     

    (1,852

    )

    (0.2

    )

     

    (1,171

    )

    (0.1

    )

    Earnings before taxes

     

    258,952

     

    27.2

     

     

    251,159

     

    26.6

     

     
    Provision for taxes

     

    47,436

     

    5.0

     

     

    49,528

     

    5.2

     

    Net earnings

    $

    211,516

     

    22.2

     

    $

    201,631

     

    21.4

     

     
    Basic earnings per common share:
    Net earnings

    $

    10.01

     

    $

    9.26

     

    Weighted average number of common shares

     

    21,139,674

     

     

    21,776,944

     

     
    Diluted earnings per common share:
    Net earnings

    $

    9.96

     

    $

    9.21

     

    Weighted average number of common and common equivalent shares

     

    21,242,343

     

     

    21,886,482

     

     
    Note:

    (a) Local currency sales increased 1% as compared to the same period in 2023.

     

    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT

     

     

     

     

     

     

     

     

     

     

    Three months ended

     

     

     

     

    Three months ended

     

     

     

    September 30, 2024

     

     

    % of sales

     

    September 30, 2023

     

    % of sales

     
    Earnings before taxes

    $

    258,952

     

    $

    251,159

     

    Amortization

     

    18,243

     

     

    18,314

     

    Interest expense

     

    18,599

     

     

    20,278

     

    Restructuring charges

     

    2,631

     

     

    7,385

     

    Other charges (income), net

     

    (1,852

    )

     

    (1,171

    )

    Adjusted operating profit

    $

    296,573

     

    (b)

    31.1

     

    $

    295,965

     

    31.4

     

     
    Note:

    (b) Adjusted operating profit was flat as compared to the same period in 2023.

     
     

    METTLER-TOLEDO INTERNATIONAL INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (amounts in thousands except share data)

    (unaudited)

     

     

    Nine months ended

     

     

     

     

    Nine months ended

     

     

     

    September 30, 2024

     

     

    % of sales

     

    September 30, 2023

     

    % of sales

     
    Net sales

    $

    2,827,234

     

    (a)

    100.0

     

    $

    2,853,317

     

    100.0

     

    Cost of sales

     

    1,140,966

     

    40.4

     

     

    1,163,669

     

    40.8

     

    Gross profit

     

    1,686,268

     

    59.6

     

     

    1,689,648

     

    59.2

     

     
    Research and development

     

    139,303

     

    4.9

     

     

    138,849

     

    4.9

     

    Selling, general and administrative

     

    698,963

     

    24.7

     

     

    680,679

     

    23.9

     

    Amortization

     

    54,649

     

    1.9

     

     

    54,135

     

    1.9

     

    Interest expense

     

    56,781

     

    2.0

     

     

    57,711

     

    2.0

     

    Restructuring charges

     

    17,624

     

    0.6

     

     

    19,680

     

    0.7

     

    Other charges (income), net

     

    (3,728

    )

    (0.1

    )

     

    (2,578

    )

    (0.2

    )

    Earnings before taxes

     

    722,676

     

    25.6

     

     

    741,172

     

    26.0

     

     
    Provision for taxes

     

    111,837

     

    4.0

     

     

    137,188

     

    4.8

     

    Net earnings

    $

    610,839

     

    21.6

     

    $

    603,984

     

    21.2

     

     
    Basic earnings per common share:
    Net earnings

    $

    28.69

     

    $

    27.54

     

    Weighted average number of common shares

     

    21,288,202

     

     

    21,933,889

     

     
    Diluted earnings per common share:
    Net earnings

    $

    28.55

     

    $

    27.37

     

    Weighted average number of common and common equivalent shares

     

    21,396,456

     

     

    22,067,398

     

     
    Note:

    (a) Local currency sales were flat as compared to the same period in 2023.

     

    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT

     

     

     

     

     

     

     

     

     

     

    Nine months ended

     

     

     

     

    Nine months ended

     

     

     

    September 30, 2024

     

     

    % of sales

     

    September 30, 2023

     

    % of sales

     
    Earnings before taxes

    $

    722,676

     

    $

    741,172

     

    Amortization

     

    54,649

     

     

    54,135

     

    Interest expense

     

    56,781

     

     

    57,711

     

    Restructuring charges

     

    17,624

     

     

    19,680

     

    Other charges (income), net

     

    (3,728

    )

     

    (2,578

    )

    Adjusted operating profit

    $

    848,002

     

    (b)

    30.0

     

    $

    870,120

     

    (b)

    30.5

     

     
    Note:

    (b) Adjusted operating profit decreased 3% as compared to the same period in 2023.

     

    METTLER-TOLEDO INTERNATIONAL INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (amounts in thousands)

    (unaudited)

     

     

     

     

     

     

     

     

     

    September 30, 2024

     

    December 31, 2023

     
    Cash and cash equivalents

    $

    71,574

     

    $

    69,807

     

    Accounts receivable, net

     

    637,202

     

     

    663,893

     

    Inventories

     

    375,813

     

     

    385,865

     

    Other current assets and prepaid expenses

     

    113,643

     

     

    110,638

     

    Total current assets

     

    1,198,232

     

     

    1,230,203

     

     
    Property, plant and equipment, net

     

    790,447

     

     

    803,374

     

    Goodwill and other intangibles assets, net

     

    934,923

     

     

    955,537

     

    Other non-current assets

     

    396,226

     

     

    366,441

     

    Total assets

    $

    3,319,828

     

    $

    3,355,555

     

     
    Short-term borrowings and maturities of long-term debt

    $

    185,824

     

    $

    192,219

     

    Trade accounts payable

     

    202,859

     

     

    210,411

     

    Accrued and other current liabilities

     

    796,285

     

     

    778,452

     

    Total current liabilities

     

    1,184,968

     

     

    1,181,082

     

     
    Long-term debt

     

    1,891,661

     

     

    1,888,620

     

    Other non-current liabilities

     

    397,552

     

     

    435,791

     

    Total liabilities

     

    3,474,181

     

     

    3,505,493

     

     
    Shareholders' equity

     

    (154,353

    )

     

    (149,938

    )

    Total liabilities and shareholders' equity

    $

    3,319,828

     

    $

    3,355,555

     

     

    METTLER-TOLEDO INTERNATIONAL INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (amounts in thousands)

    (unaudited)

     

     

     

     

     

     

     

     

     

    Three months ended

     

    Nine months ended

     

    September 30,

     

    September 30,

     

    2024

     

    2023

     

    2024

     

    2023

     
    Cash flow from operating activities:
    Net earnings

    $

    211,516

     

    $

    201,631

     

    $

    610,839

     

    $

    603,984

     

    Adjustments to reconcile net earnings to net cash provided by operating activities:
    Depreciation

     

    12,836

     

     

    12,189

     

     

    37,709

     

     

    36,406

     

    Amortization

     

    18,243

     

     

    18,314

     

     

    54,649

     

     

    54,135

     

    Deferred tax benefit

     

    (1,224

    )

     

    (2,689

    )

     

    (5,061

    )

     

    (4,455

    )

    One-time non-cash discrete tax benefit

     

    -

     

     

    -

     

     

    (22,982

    )

     

    -

     

    Other

     

    4,359

     

     

    4,228

     

     

    13,622

     

     

    12,450

     

    Increase (decrease) in cash resulting from changes in operating assets and liabilities

     

    8,936

     

     

    30,623

     

     

    13,383

     

     

    (18,151

    )

    Net cash provided by operating activities

     

    254,666

     

     

    264,296

     

     

    702,159

     

     

    684,369

     

     
    Cash flows from investing activities:
    Proceeds from sale of property, plant and equipment

     

    65

     

     

    256

     

     

    733

     

     

    668

     

    Purchase of property, plant and equipment

     

    (21,421

    )

     

    (20,960

    )

     

    (62,622

    )

     

    (72,907

    )

    Proceeds from government funding (a)

     

    -

     

     

    1,332

     

     

    -

     

     

    2,596

     

    Acquisitions

     

    -

     

     

    -

     

     

    (2,473

    )

     

    (613

    )

    Other investing activities

     

    (16,287

    )

     

    (11,523

    )

     

    (4,048

    )

     

    (25,937

    )

    Net cash used in investing activities

     

    (37,643

    )

     

    (30,895

    )

     

    (68,410

    )

     

    (96,193

    )

    Cash flows from financing activities:
    Proceeds from borrowings

     

    539,071

     

     

    489,052

     

     

    1,561,649

     

     

    1,569,973

     

    Repayments of borrowings

     

    (559,670

    )

     

    (508,497

    )

     

    (1,576,862

    )

     

    (1,467,228

    )

    Proceeds from exercise of stock options

     

    14,203

     

     

    147

     

     

    22,339

     

     

    19,234

     

    Repurchases of common stock

     

    (212,499

    )

     

    (223,999

    )

     

    (637,497

    )

     

    (723,998

    )

    Acquisition contingent consideration payment

     

    -

     

     

    (2,141

    )

     

    -

     

     

    (7,767

    )

    Other financing activities

     

    (3

    )

     

    (112

    )

     

    (1,913

    )

     

    (826

    )

    Net cash used in financing activities

     

    (218,898

    )

     

    (245,550

    )

     

    (632,284

    )

     

    (610,612

    )

     
    Effect of exchange rate changes on cash and cash equivalents

     

    2,639

     

     

    (1,750

    )

     

    302

     

     

    (3,855

    )

     
    Net increase (decrease) in cash and cash equivalents

     

    764

     

     

    (13,899

    )

     

    1,767

     

     

    (26,291

    )

     
    Cash and cash equivalents:
    Beginning of period

     

    70,810

     

     

    83,574

     

     

    69,807

     

     

    95,966

     

    End of period

    $

    71,574

     

    $

    69,675

     

    $

    71,574

     

    $

    69,675

     

     
    RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
     
    Net cash provided by operating activities

    $

    254,666

     

    $

    264,296

     

    $

    702,159

     

    $

    684,369

     

    Payments in respect of restructuring activities

     

    4,086

     

     

    7,544

     

     

    19,766

     

     

    14,942

     

    Transition tax payment

     

    -

     

     

    -

     

     

    10,723

     

     

    8,042

     

    Proceeds from sale of property, plant and equipment

     

    65

     

     

    255

     

     

    733

     

     

    667

     

    Purchase of property, plant and equipment, net (a)

     

    (21,421

    )

     

    (20,362

    )

     

    (62,622

    )

     

    (65,177

    )

    Acquisition payments (b)

     

    -

     

     

    -

     

     

    -

     

     

    4,775

     

    Adjusted free cash flow

    $

    237,396

     

    $

    251,733

     

    $

    670,759

     

    $

    647,618

     

     
    Notes:
    (a) In September 2021, the Company entered into an agreement with the U.S. Department of Defense to increase the domestic production capacity of pipette tips and enhance manufacturing automation and logistics. The Company received funding of $35.8 million in prior years, which offset capital expenditures. During the three and nine months ended September 30, 2023 the Company received funding proceeds of $1.3 million and $2.6 million, respectively. During the three and nine months ended September 30, 2023 the related purchase of property, plant and equipment of $0.6 million and $7.7 million, respectively, are excluded from Adjusted free cash flow.
    (b) Includes $4.4 million of the PendoTECH contingent consideration payment that was reported in net cash provided by operating activities as required by U.S. GAAP for the nine months ended September 30, 2023.
     
    METTLER-TOLEDO INTERNATIONAL INC.
    OTHER OPERATING STATISTICS
     
     
    SALES GROWTH BY DESTINATION
    (unaudited)
     
    Americas Europe Asia/RoW Total
     
    U.S. Dollar Sales Growth
    Three Months Ended September 30, 2024

    (1

    %)

    2

    %

    4

    %

    1

    %

    Nine Months Ended September 30, 2024

    1

    %

    5

    %

    (8

    %)

    (1

    %)

     
    Local Currency Sales Growth
    Three Months Ended September 30, 2024

    (1

    %)

    1

    %

    4

    %

    1

    %

    Nine Months Ended September 30, 2024

    1

    %

    4

    %

    (6

    %)

    0

    %

     
    Note:
    (a) The Company estimates net sales for the nine months ended September 30, 2024 benefited by 2% from recovering previously delayed shipments from the fourth quarter of 2023. By geographic destination, net sales benefited approximately 1% in the Americas, 4% in Europe and 1% in Asia/Rest of World.

    RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS

    (unaudited)

     

     

    Three months ended

     

    Nine months ended

     

    September 30,

     

    September 30,

     

    2024

     

    2023

     

    % Growth

     

    2024

     

    2023

     

    % Growth

     
    EPS as reported, diluted

    $

    9.96

     

    $

    9.21

    8

    %

    $

    28.55

     

    $

    27.37

     

    4

    %

     
    Purchased intangible amortization, net of tax

     

    0.23

     

    (a)

     

    0.24

    (a)

     

    0.71

     

    (a)

     

    0.70

     

    (a)
    Restructuring charges, net of tax

     

    0.10

     

    (b)

     

    0.27

    (b)

     

    0.67

     

    (b)

     

    0.72

     

    (b)
    Income tax expense

     

    (0.08

    )

    (c)

     

    0.08

    (c)

     

    (1.19

    )

    (c)

     

    (0.16

    )

    (c)
     
    Adjusted EPS, diluted

    $

    10.21

     

    $

    9.80

    4

    %

    $

    28.74

     

    $

    28.63

     

    0

    %

     
    Notes:
    (a) Represents the EPS impact of purchased intangibles amortization of $6.4 million ($5.0 million after tax) and $6.7 million ($5.2 million after tax) for the three months ended September 30, 2024 and 2023, and $19.5 million ($15.1 million after tax) and $20.0 million ($15.4 million after tax) for the nine months ended September 30, 2024 and 2023, respectively.
    (b) Represents the EPS impact of restructuring charges of $2.6 million ($2.1 million after tax) and $7.4 million ($6.0 million after tax) for the three months ended September 30, 2024 and 2023, and $17.6 million ($14.3 million after tax) and $19.7 million ($15.9 million after tax) for the nine months ended September 30, 2024 and 2023, respectively, which primarily include employee related costs.
    (c) Represents the EPS impact of the difference between our quarterly and estimated annual tax rate before non-recurring discrete items during the three and nine months ended September 30, 2024 and 2023 due to the timing of excess tax benefits associated with stock option exercises. Also includes a reported EPS reduction of $1.07 for the nine months ended September 30, 2024 for a non-cash discrete tax benefit resulting from the reduction of uncertain tax position liabilities related to the settlement of a tax audit.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241107177327/en/

    Get the next $MTD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    5/20/2025$1350.00Neutral → Buy
    UBS
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    1/2/2025$1375.00 → $1450.00In-line → Outperform
    Evercore ISI
    12/13/2024Peer Perform
    Wolfe Research
    12/11/2024$1200.00 → $1300.00Sell → Neutral
    Citigroup
    8/28/2024$1400.00Equal Weight
    Wells Fargo
    More analyst ratings

    $MTD
    SEC Filings

    See more
    • SEC Form SD filed by Mettler-Toledo International Inc.

      SD - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/30/25 8:39:40 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/12/25 4:47:54 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/6/25 11:25:47 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2025 Healthcare Conference

      Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide

      4/25/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Financials

    Live finance-specific insights

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Reports Fourth Quarter 2024 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2024. Provided below are the highlights: Reported and local currency sales increased 12% compared with the prior year. Net earnings per diluted share as reported (EPS) were $11.96, compared with $8.52 in the prior-year period. Adjusted EPS was $12.41, an increase of 32% over the prior-year amount of $9.40. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We had a strong finish to the year as we capitalized on very good customer deman

      2/6/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/13/24 5:09:38 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/23 1:38:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/22 5:03:51 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mettler-Toledo upgraded by UBS with a new price target

      UBS upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,350.00

      5/20/25 8:01:57 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,110.00

      5/5/25 8:42:51 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,100.00

      5/5/25 8:26:45 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      11/15/23 9:00:20 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    See more
    • Mettler-Toledo International Inc. Announces Change to Board of Directors

      Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier Filliol informed the Company that he will not stand for re-election to the Board of Directors in May 2023. Mr. Filliol joined the Board in 2009 and served as President and CEO from January 1, 2008 through March 31, 2021.  Robert F. Spoerry, Chair of the Board, stated, "We want to sincerely thank Olivier for his many highly valuable contributions, and we are grateful for the unique expertise that he has brought to the Company. Olivier was instrumental in ensuring a successful CEO transition to Patrick Kaltenbach, which positions the Company well to continue its successf

      11/23/22 8:00:00 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kelly Michael A sold $1,231,846 worth of shares (1,062 units at $1,159.93) and exercised 1,062 shares at a strike of $312.36 (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/30/25 8:45:39 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Process Analytics Keller Gerry was granted 88 shares, increasing direct ownership by 1,467% to 94 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/12/25 5:14:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Eur & NA Market Orgs De La Guerroniere Marc was granted 186 shares (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/12/25 5:13:12 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials